Literature DB >> 27378582

Burden of Keloid Disease: A Cross-sectional Health-related Quality of Life Assessment.

Eveline Bijlard1, Casimir A E Kouwenberg, Reinier Timman, Steven E R Hovius, Jan J V Busschbach, Marc A M Mureau.   

Abstract

Keloid scars may be painful, itch severely and be cosmetically disturbing. The burden of keloid disease, however, has not yet been determined. This study evaluated the association of keloid disease with health-related quality of life (HRQL) and identified indicators of burden using a cross-sectional survey study, with one disease-specific HRQL measure (Skindex-29) and 2 generic HRQL measures (SF-36 and EQ-5D-5L). A total of 106 keloid patients with no other skin diseases participated in the study. Having keloid disease was associated with a considerable impairment of emotional wellbeing, with most impairment on the emotional and mental HRQL. Pain and itch were the strongest indicators of HRQL impairment in keloid patients. Having painful or itchy keloids was related to low mental and emotional HRQL, implying that patients with keloids require access to effective treatment aimed at alleviating physical symptoms.

Entities:  

Mesh:

Year:  2017        PMID: 27378582     DOI: 10.2340/00015555-2498

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  23 in total

Review 1.  A Retrospective Registry Study Evaluating the Long-Term Efficacy and Safety of Superficial Radiation Therapy Following Excision of Keloid Scars.

Authors:  Brian Berman; Mark S Nestor; Michael H Gold; David J Goldberg; Eduardo T Weiss; Isabelle Raymond
Journal:  J Clin Aesthet Dermatol       Date:  2020-10-01

2.  Effects on quality of life and psychosocial wellbeing in Chinese patients with keloids.

Authors:  Wensheng Lu; Haifeng Chu; Xiaodong Zheng
Journal:  Am J Transl Res       Date:  2021-03-15       Impact factor: 4.060

3.  STAT3 signalling pathway is implicated in keloid pathogenesis by preliminary transcriptome and open chromatin analyses.

Authors:  Yun-Shain Lee; Ya-Chen Liang; Ping Wu; David A Kulber; Kylie Tanabe; Cheng-Ming Chuong; Randall Widelitz; Tai-Lan Tuan
Journal:  Exp Dermatol       Date:  2019-04       Impact factor: 3.960

Review 4.  Pruritus in Keloid Scars: Mechanisms and Treatments.

Authors:  Ahmed A Hawash; Giuseppe Ingrasci; Keyvan Nouri; Gil Yosipovitch
Journal:  Acta Derm Venereol       Date:  2021-10-28       Impact factor: 3.875

5.  Scar-centered dilation in the treatment of large keloids.

Authors:  Min Wu; Jie-Yu Gu; Ran Duan; Bo-Xuan Wei; Feng Xie
Journal:  World J Clin Cases       Date:  2022-06-26       Impact factor: 1.534

6.  Downregulated cytotoxic CD8+ T-cell identifies with the NKG2A-soluble HLA-E axis as a predictive biomarker and potential therapeutic target in keloids.

Authors:  Heng Xu; Zhu Zhu; Jian Hu; Jiawei Sun; Yan Wo; Xianshu Wang; Hongzhi Zou; Bin Li; Yixin Zhang
Journal:  Cell Mol Immunol       Date:  2022-01-17       Impact factor: 22.096

Review 7.  MicroRNA-21 in Skin Fibrosis: Potential for Diagnosis and Treatment.

Authors:  Yan Li; Juan Zhang; Yuying Lei; Lechun Lyu; Ruiling Zuo; Ting Chen
Journal:  Mol Diagn Ther       Date:  2017-12       Impact factor: 4.074

Review 8.  Biological approaches for hypertrophic scars.

Authors:  Zhong Lingzhi; Li Meirong; Fu Xiaobing
Journal:  Int Wound J       Date:  2019-12-20       Impact factor: 3.315

9.  Massive ear keloids: Natural history, evaluation of risk factors and recommendation for preventive measures - A retrospective case series.

Authors:  Michael Tirgan
Journal:  F1000Res       Date:  2016-10-13

10.  Comorbidities of scars in China: a national study based on hospitalized cases.

Authors:  Weishi Kong; Yongqiang Xiao; Baoli Wang; Zhe Zhu; Lunyang Hu; Hongtai Tang; Kangan Wang; He Fang; Ying Shi; Jianyan Long; Lanxia Gan; Haibo Wang; Yu Sun; Zhaofan Xia
Journal:  Burns Trauma       Date:  2021-06-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.